These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 865409)

  • 21. Jaundice and oxyphenisatin.
    McHardy G; Balart LA
    JAMA; 1970 Jan; 211(1):83-5. PubMed ID: 5466895
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hepatitis caused by laxatives. Oxyphenisatin-induced jaundice].
    Dahinden U; Filippini L; Rondez R
    Schweiz Med Wochenschr; 1973 Jul; 103(27):960-4. PubMed ID: 4715475
    [No Abstract]   [Full Text] [Related]  

  • 23. Unusual case of skin discoloration.
    Darke CS; Cooper RG
    Br Med J; 1978 May; 1(6121):1188-9. PubMed ID: 638688
    [No Abstract]   [Full Text] [Related]  

  • 24. Recurrent jaundice induced by oxyphenisatin.
    Fischer MG; Weiss B; Babar A
    Am J Gastroenterol; 1972 Jul; 58(1):58-65. PubMed ID: 5046742
    [No Abstract]   [Full Text] [Related]  

  • 25. [Drug-induced chronic aggressive hepatitis].
    Rotermund HM
    Med Klin; 1977 Dec; 72(50):2139-45. PubMed ID: 593197
    [No Abstract]   [Full Text] [Related]  

  • 26. Letter: Aspirin, bile salts, and dioctyl sodium sulphosuccinate.
    Godding EW
    Br Med J; 1975 Mar; 1(5960):733. PubMed ID: 1125680
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug-induced chronic hepatitis.
    Wright R
    Springer Semin Immunopathol; 1980 Dec; 3(3):331-8. PubMed ID: 7022714
    [No Abstract]   [Full Text] [Related]  

  • 28. [Drug-induced liver damage; new aspects on its mechanism].
    Salaspuro M
    Duodecim; 1980; 96(5):394-402. PubMed ID: 6893817
    [No Abstract]   [Full Text] [Related]  

  • 29. Oxyphenisatin and liver damage.
    Watson D
    Med J Aust; 1972 Aug; 2(9):510. PubMed ID: 5083605
    [No Abstract]   [Full Text] [Related]  

  • 30. [Electron microscopy picture of oxyphenisatin-induced liver damage].
    Merker HJ; Henning H; Vogel HM
    Z Gastroenterol; 1976 Dec; 14(8):779-95. PubMed ID: 1014772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Rules for the histological evaluation of drug-induced liver lesions].
    Bianchi L; De Groote J; Desmet V; Gedigk P; Korb G; Popper H; Poulsen H; Scheuer PJ; Schmid M; Thaler H; Wepler W
    Dtsch Med Wochenschr; 1975 Aug; 100(35):1746-50. PubMed ID: 1157673
    [No Abstract]   [Full Text] [Related]  

  • 32. [Drug-induced active hepatitis (author's transl)].
    Labayle D; Lenoir C; Buffet C; Chaput JC; Etienne P
    Nouv Presse Med; 1979 Jun; 8(24):2013-5. PubMed ID: 386256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Oxyphenisatin-induced liver disease (author's transl)].
    Lindner H; du Bosque G; Dammermann R; Klöppel G; Krause D
    Dtsch Med Wochenschr; 1975 Dec; 100(49):2530-5. PubMed ID: 127699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-induced chronic hepatitis and cirrhosis.
    Maddrey WC; Boitnott JK
    Prog Liver Dis; 1979; 6():595-603. PubMed ID: 396573
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug-related acute and chronic hepatitis.
    Maddrey WC
    Clin Gastroenterol; 1980 Jan; 9(1):213-24. PubMed ID: 6994951
    [No Abstract]   [Full Text] [Related]  

  • 36. [Danthron prohibition].
    Ippen H
    Dtsch Med Wochenschr; 1987 Apr; 112(14):569-70. PubMed ID: 3829944
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-term effects on the liver.
    Scheuer PJ
    J Clin Pathol Suppl (R Coll Pathol); 1975; 9():71-4. PubMed ID: 182727
    [No Abstract]   [Full Text] [Related]  

  • 38. [Oxyphenisatin, a laxative responsible for chronic hepatitis and cirrhosis, still marketed in France (author's transl)].
    Delchier JC; Métreau JM; Lévy VG; Opolon P; Dhumeaux D
    Nouv Presse Med; 1979 Oct; 8(37):2955-8. PubMed ID: 503828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical aspects of chronic hepatitis. Diagnosis and differential diagnosis].
    Heissmeyer HH
    ZFA (Stuttgart); 1978 Mar; 54(7):372-8. PubMed ID: 636532
    [No Abstract]   [Full Text] [Related]  

  • 40. The incidence of oxyphenisatin-induced liver damage in chronic non-alcoholic liver disease. A controlled investigation.
    Dietrichson O; Juhl E; Nielsen JO; Oxlund JJ; Christoffersen P
    Scand J Gastroenterol; 1974; 9(5):473-8. PubMed ID: 4605276
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.